A bacterial vaccine with the potential to target glioblastoma, cancer and others infections diseases

Background

Vaccines that target antigen specific cellular immune response could cure cancer and many infectious diseases. Despite many advances in this field, technologies for vectorisation of proteic antigens remains to be optimised for the development of vaccines.